Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - RESEARCH & DEVELOPMENT
Research & Development ALLO - Allogene Therapeutics, Inc.
243 M
LAST VALUE
5.04%
2 YEAR CAGR
9.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR